Ablation of the thyroid remnant and I-131 dose in differentiated thyroid cancer: a meta-analysis revisited.
作者信息
Doi Suhail A R, Woodhouse Nicholas J, Thalib Lukman, Onitilo Adedayo
机构信息
Department of Medicine (Endocrinology), Mubarak Al-Kabeer Teaching Hospital and Kuwait University Kuwait .
出版信息
Clin Med Res. 2007 Jun;5(2):87-90. doi: 10.3121/cmr.2007.763.
Abstract
摘要
相似文献
1
Ablation of the thyroid remnant and I-131 dose in differentiated thyroid cancer: a meta-analysis revisited.
Clin Med Res. 2007 Jun;5(2):87-90. doi: 10.3121/cmr.2007.763.
2
Low versus high I-131 dose for remnant ablation in differentiated thyroid cancer.
Clin Med Res. 2009 Jun;7(1-2):1; author reply 2-3. doi: 10.3121/cmr.2009.841.
3
High recurrent rate of multicentric papillary thyroid carcinoma.
Ann Surg Oncol. 2009 Sep;16(9):2609-16. doi: 10.1245/s10434-009-0565-7. Epub 2009 Jun 16.
4
Re: Extent of surgery affects papillary thyroid cancer.
Ann Surg. 2008 Jun;247(6):1082-3; author reply 1083-4. doi: 10.1097/SLA.0b013e3181758d93.
5
Role of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: Memorial Sloan-kettering Cancer Center experience.
Int J Radiat Oncol Biol Phys. 2009 Mar 1;73(3):795-801. doi: 10.1016/j.ijrobp.2008.05.012.
6
Papillary microcarcinoma of the thyroid.
J Surg Oncol. 2007 Jun 1;95(7):532-3. doi: 10.1002/jso.20743.
7
[Thyroid cancer. Classification and prognosis of 603 cases].
Presse Med (1893). 1968 Nov 2;76(42):2003-5.
8
Long-term recurrence of thyroid cancer after thyroid remnant ablation with 1.1 and 3.7 GBq radioiodine.
Nucl Med Commun. 2007 Jun;28(6):507-8. doi: 10.1097/MNM.0b013e3281744458.
9
Incidence of radiation thyroiditis and thyroid remnant ablation success rates following 1110 MBq (30 mCi) and 3700 MBq (100 mCi) post-surgical 131I ablation therapy for differentiated thyroid carcinoma.
Clin Endocrinol (Oxf). 2008 Dec;69(6):957-62. doi: 10.1111/j.1365-2265.2008.03276.x. Epub 2008 Apr 12.
10
The evolving role of (131)I for the treatment of differentiated thyroid carcinoma.
J Nucl Med. 2005 Jan;46 Suppl 1:28S-37S.
引用本文的文献
1
Update on lacrimal apparatus dysfunction associated with differentiated thyroid cancer after I-131 therapy.
Int Ophthalmol. 2024 Jun 23;44(1):257. doi: 10.1007/s10792-024-03192-9.
2
Association between the detection rate of thyroid cancer and the external radiation dose-rate after the nuclear power plant accidents in Fukushima, Japan.
Medicine (Baltimore). 2019 Sep;98(37):e17165. doi: 10.1097/MD.0000000000017165.
3
Differentiated thyroid cancer theranostics: radioiodine and beyond.
Br J Radiol. 2018 Nov;91(1091):20180136. doi: 10.1259/bjr.20180136. Epub 2018 Oct 11.
4
I-131 for Remnant Ablation in Differentiated Thyroid Cancer After Thyroidectomy: A Meta-Analysis of Randomized Controlled Evidence.
Med Sci Monit. 2016 Jul 13;22:2439-50. doi: 10.12659/msm.896535.
5
A comparison of low versus high radioiodine administered activity in patients with low-risk differentiated thyroid cancer.
Eur Arch Otorhinolaryngol. 2017 Feb;274(2):655-660. doi: 10.1007/s00405-016-4111-5. Epub 2016 May 25.
6
Drug-induced liver injury caused by iodine-131.
Clin Mol Hepatol. 2016 Jun;22(2):272-5. doi: 10.3350/cmh.2015.0037. Epub 2016 May 20.
7
Preablation Stimulated Thyroglobulin/TSH Ratio as a Predictor of Successful I(131)Remnant Ablation in Patients with Differentiated Thyroid Cancer following Total Thyroidectomy.
J Thyroid Res. 2014;2014:610273. doi: 10.1155/2014/610273. Epub 2014 Apr 9.
8
Differentiated thyroid cancer-personalized therapies to prevent overtreatment.
Nat Rev Endocrinol. 2014 Sep;10(9):563-74. doi: 10.1038/nrendo.2014.100. Epub 2014 Jul 1.
9
Radioiodine therapy for patients with differentiated thyroid cancer after thyroidectomy: direct comparison and network meta-analyses.
J Endocrinol Invest. 2013 Nov;36(10):896-902. doi: 10.3275/8998. Epub 2013 May 30.
10
Radioiodine for remnant ablation and therapy of metastatic disease.
Nat Rev Endocrinol. 2011 Aug 9;7(10):589-95. doi: 10.1038/nrendo.2011.134.
本文引用的文献
1
131I activity for remnant ablation in patients with differentiated thyroid cancer: A systematic review.
J Clin Endocrinol Metab. 2007 Jan;92(1):28-38. doi: 10.1210/jc.2006-1345. Epub 2006 Oct 10.
2
Follow-up of differentiated thyroid carcinoma.
Minerva Endocrinol. 2004 Dec;29(4):161-74.
3
Prognostic significance of successful ablation with radioiodine of differentiated thyroid cancer patients.
Eur J Endocrinol. 2005 Jan;152(1):33-7. doi: 10.1530/eje.1.01819.
4
Efficacy of low and high 131I doses for thyroid remnant ablation in patients with differentiated thyroid carcinoma based on post-operative cervical uptake.
Nucl Med Commun. 2004 Nov;25(11):1077-81. doi: 10.1097/00006231-200411000-00002.
5
Efficacy of I131 ablation therapy using different doses as determined by postoperative thyroid scan uptake in patients with differentiated thyroid cancer.
Int J Radiat Oncol Biol Phys. 2004 Aug 1;59(5):1330-6. doi: 10.1016/j.ijrobp.2004.01.036.
6
Radioiodine dose for remnant ablation in differentiated thyroid carcinoma: a randomized clinical trial in 509 patients.
J Clin Endocrinol Metab. 2004 Apr;89(4):1666-73. doi: 10.1210/jc.2003-031152.
7
Radioiodine-131 in differentiated thyroid cancer: a retrospective analysis of an uptake-related ablation strategy.
Eur J Nucl Med Mol Imaging. 2004 Apr;31(4):499-506. doi: 10.1007/s00259-003-1405-9. Epub 2004 Jan 14.
8
[Early evaluation of treatment effectiveness using 131I iodine radiotherapy in patients with differentiated thyroid cancer].
Wiad Lek. 2001;54 Suppl 1:278-88.
9
Ablation of the thyroid remnant and 131I dose in differentiated thyroid cancer.
Clin Endocrinol (Oxf). 2000 Jun;52(6):765-73.
10
Prescribing 131Iodine based on neck uptake produces effective thyroid ablation and reduced hospital stay.
Radiother Oncol. 1998 Jun;47(3):325-30. doi: 10.1016/s0167-8140(98)00012-7.
Zotero 插件